Clinical Trials Logo

Bile Duct Diseases clinical trials

View clinical trials related to Bile Duct Diseases.

Filter by:
  • Active, not recruiting  
  • Page 1 ·  Next »

NCT ID: NCT05014347 Active, not recruiting - Pancreatic Diseases Clinical Trials

Patient Reported Experience in Endoscopic Ultrasound

PREUS
Start date: June 1, 2021
Phase:
Study type: Observational

The evaluation of the patient's experience is becoming increasingly important as a better patient experience can improve the quality of the delivered health service. Patient-reported experience measures (PREMs) are self-reported assessment tools provided by patients about their experience during any health event. There are few PREMs's instruments in the field of gastrointestinal endoscopy, and none is specific for Endoscopic Ultrasound (EUS). The aim of this study is to develop a questionnaire to evaluate the experience of patients undergoing EUS, identifying and prioritizing the factors related to the patient's experience. In order of it, expected results are developing a valid tool of question to value patients experience during EUS and, for ranking, it is iphotized that will be more correlation with patients's and nurses's answer that clinicians's one. In literature is described that nurse's view and patient's view are more similar especially in those aspects concerning empatics and psychological aspects.

NCT ID: NCT04637243 Active, not recruiting - Clinical trials for Benign or Malignant Liver and Bile Duct Disease

Outcomes From Treatment Liver and Bile Duct Diseases

Start date: March 9, 2023
Phase:
Study type: Observational

It is reported in the literature that the treatment of any liver and bile duct disease process, whether benign or malignant, continues to be a huge challenge. For example, patients with adenocarcinoma continue to be diagnosed at an advanced stage with medical and surgical options that are improving in terms of outcome measurements but with much more room for improvement. Our goal is to continue to review our treatment outcomes to further improve overall survival, overall symptom control, mortality and morbidity. The main aim of this study is to evaluate and compare the outcomes from our multiple treatments of benign or malignant liver and bile duct diseases.

NCT ID: NCT03678441 Active, not recruiting - Clinical trials for Liver and Intrahepatic Bile Duct Disorder

Electronic Neurocognitive Tools in Screening for Mental Capability in Patients Undergoing Liver Surgery

Start date: August 17, 2018
Phase: N/A
Study type: Interventional

This trial studies how well electronic neurocognitive tools work in screening for mental capability in patients who are undergoing liver surgery. Using electronic neurocognitive screening tools may help to better assess mental impairment.

NCT ID: NCT03190343 Active, not recruiting - Clinical trials for Biliary Tract Diseases

Assessment of Cholangio-pancreatoscopy for the Diagnosis and the Treatment of Biliary and Pancreatic Diseases

Start date: November 2016
Phase:
Study type: Observational [Patient Registry]

The biliary and pancreatic tumors are rare but the prognosis is pejorative. It was difficult to have histology of these tumors as the samples taken during ERCP were performed under " blind " radiology control. So the diagnostic accuracy was insufficient. The arrival of A new optic fiber endoscope used by only one operator had improved the diagnostic of bilio-pancreatic diseases. However this technology with optic fiber quickly had proved outdated for several reasons: poor manoeuvrability, perfectible optical vision, optical fibers fragility and cost. A new generation of endoscopes with digital vision appeared and would allow an increase in diagnostic accuracy related to better vision and manoeuvrability. The purpose of the study is to assess the interest of the cholangio pancreatoscopy performed with digital vision.

NCT ID: NCT02611453 Active, not recruiting - Choledocholithiasis Clinical Trials

Cholangiography Using Carbon Dioxide Versus Iodinated Contrast in ERCP

Start date: February 2016
Phase: N/A
Study type: Interventional

Carbon dioxide (CO2) gas is widely used for luminal insufflation during endoscopic retrograde cholangiopancreatography (ERCP) of the biliary tract. While frequently observed during routine ERCP, there are few data on the topic of "air" or "CO2" cholangiography. Our primary aim is to compare radiographic cholangiograms in patients with biliary tract disease (from stones or strictures) during ERCP obtained by using carbon dioxide as the contrast medium vs. conventional iodinated contrast.

NCT ID: NCT02189421 Active, not recruiting - Clinical trials for Biliary Tract Cancer

Multibending vs Conventional Endoscope for Direct Peroral Cholangioscopy

Start date: April 2014
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the usefulness of a newly developed multibending ultra-slim upper endoscope for the successful direct peroral cholangioscopy (POC) without assisting accessory in comparison with conventional ultra-slim endoscope. The investigators expect that multibending endoscope will show more higher successful performance than conventional endoscope.

NCT ID: NCT02156739 Active, not recruiting - Clinical trials for Hepatocellular Carcinoma

Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions

Start date: October 13, 2014
Phase: N/A
Study type: Interventional

This clinical trial studies contrast-enhanced magnetic resonance imaging (MRI) in detecting nonmalignant and malignant liver lesions. Diagnostic procedures, such as MRI, may help find and diagnose nonmalignant and malignant liver lesions. Contrast agents, such as gadoxetate disodium and gadobutrol, may help doctors to see MRI images more clearly.

NCT ID: NCT01275768 Active, not recruiting - Clinical trials for Disorder of Bile Duct Stent

Role of Endoscopic RFA in Prolonging the Patency of Metal Stents in Patients With Malignant Obstructive Jaundice

Start date: January 2011
Phase: Phase 1/Phase 2
Study type: Interventional

Patients with malignant obstructive jaundice (cancer of head of pancreas and cholangiocarcinoma) generally have a very poor prognosis with less than 20% patients having resectable disease at presentation. These patients also have a very poor quality of life with a life expectancy of 6-8 months. Jaundice associated with pruritus, poor appetite, malabsorption and loss of weight and cholangitis is the most common and troublesome problem. Placement of metallic stents has been the standard of care for patients with unresectable disease. However, about 50% of these stents get blocked in 6-8 months. Use of endoscopic Radio-frequency Ablation (RFA) prior to placement of metal stents may increase the patency of these stents

NCT ID: NCT00840138 Active, not recruiting - Cholecystectomy Clinical Trials

A Comparison of Bile Duct Injuries Following Open Cholecystectomy Versus Laparoscopic Cholecystectomy

Start date: January 1996
Phase: N/A
Study type: Observational

In this prospective study the investigators compared common bile duct injuries (CBDI) following laparoscopic cholecystectomy (LC) and open cholecystectomy (OC) procedures, 35 patients in each group. To date, no detailed study concerning this matter has been published. LC - CBDI in comparison with OC - CBDI more often concerned young females with a narrow CBD, they were located closer to the liver hilus, and they were more extended.

NCT ID: NCT00270868 Active, not recruiting - Bile Duct Diseases Clinical Trials

Efficacy of Double Wire Technique in Difficult Cases of Common Bile Duct Cannulation in ERCP (UDOGUIA-04)

Start date: November 2004
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if the double guide wire technique is more effective than the conventional method in those cases of difficult selective biliary cannulation in the ERCP procedures.